SEC Form 4 · accession 0001209191-16-136747

Xylem Inc. · XYL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Aug 10, 2016

Accepted (ET)

Aug 12, 2016 · 1:46 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001524472

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Aug 10, 2016	M	5,155	$30.03	A	11,243	D
Common Stock^F1	Aug 10, 2016	S	5,155	$48.00	D	6,088	D
Common Stock^F1	Aug 11, 2016	M	28,732	$30.03	A	34,820	D
Common Stock^F1,F2	Aug 11, 2016	S	28,732	$48.13	D	6,088	D
Common Stock	holding	—	—		—	80,367	I	By Steven R. Loranger Revocable Trust
Common Stock	holding	—	—		—	50,551	I	By Betsy Palmer Loranger Revocable Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$30.03	Aug 10, 2016	M	5,155	D	—	Oct 31, 2018	Common Stock	5,155	94,864	D
Stock Option (Right to Buy)^F3	$30.03	Aug 11, 2016	M	28,732	D	—	Oct 31, 2018	Common Stock	28,732	66,132	D

F1The exercise and sale was made under a 10b5-1 plan adopted by the reporting person on June 1, 2016.
F2This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $48.00 to $48.27 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
F3These options are fully vested and exercisable.